Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Repurchased
Ratios

Dexcom (DXCM) Shares Outstanding (2016 - 2022)

Historic Shares Outstanding for Dexcom (DXCM) over the last 14 years, with Q1 2022 value amounting to $98.1 million.

  • Dexcom's Shares Outstanding rose 144.78% to $98.1 million in Q1 2022 from the same period last year, while for Mar 2022 it was $98.1 million, marking a year-over-year increase of 144.78%. This contributed to the annual value of $97.0 million for FY2021, which is 93.65% up from last year.
  • Latest data reveals that Dexcom reported Shares Outstanding of $98.1 million as of Q1 2022, which was up 144.78% from $97.0 million recorded in Q4 2021.
  • In the past 5 years, Dexcom's Shares Outstanding ranged from a high of $98.1 million in Q1 2022 and a low of $88.1 million during Q1 2018
  • In the last 5 years, Dexcom's Shares Outstanding had a median value of $92.3 million in 2020 and averaged $93.3 million.
  • Its Shares Outstanding has fluctuated over the past 5 years, first skyrocketed by 491.8% in 2020, then skyrocketed by 93.65% in 2021.
  • Dexcom's Shares Outstanding (Quarter) stood at $90.0 million in 2018, then grew by 1.78% to $91.6 million in 2019, then grew by 4.91% to $96.1 million in 2020, then rose by 0.94% to $97.0 million in 2021, then increased by 1.13% to $98.1 million in 2022.
  • Its last three reported values are $98.1 million in Q1 2022, $97.0 million for Q4 2021, and $96.9 million during Q3 2021.